Omega 3 BasiX 30 Softgels

Omega 3 BasiX™ provides a clearly measured source of long-chain omega-3 fatty acids in an absorption-ready format. Its panel lists 430 mg of total omega-3s, with EPA at 300 mg; DHA at 130 mg; and DPA at 12 mg in each softgel. XYMOGEN pairs that fatty-acid profile with MaxSimil® lipid technology and states that the resulting monoacylglycerides increase uptake relative to ethyl ester and triglyceride fish oils. The formula is also IFOS certified, a manufacturer-stated marker addressing fish-oil purity, freshness, and sustainability. These details make the product useful for adults who want to know both which marine fatty acids they are taking and the exact labeled contribution of each. Rather than relying on a generic fish-oil total, the panel separates EPA, DHA, and DPA so a practitioner can review the profile against the person’s diet and broader supplement plan.

Omega 3 BasiX™ is intended for adults who want a daily supplement providing the three named marine fats EPA, DHA, and DPA, especially when fatty fish is not a consistent part of their food pattern. The enteric-coated softgel may suit someone who values a compact format and wants MaxSimil® monoacylglyceride technology rather than a conventional ethyl ester presentation. Its 300 mg of EPA and 130 mg of DHA allow a healthcare professional to judge the actual long-chain omega-3 intake without estimating from total fish oil alone. Because the softgel contains fish-derived gelatin and fish oil, it is not appropriate for a person avoiding fish. Anyone using a blood thinner or another medication should have the complete ingredient list reviewed before adding it. The labeled once-daily direction also makes the product a straightforward option for a supervised foundational nutrition routine.

Omega 3 BasiX™ contains fish oil and fish gelatin, so people with a fish allergy or those who avoid animal-derived ingredients should not treat it as suitable. The manufacturer’s caution states: “Consult your healthcare professional before use. Individuals taking blood thinners or other medication should discuss potential interactions with their healthcare professional. Do not use if tamper seal is damaged.” That medication language is particularly relevant because the product supplies concentrated EPA, DHA, and DPA rather than an unspecified culinary amount of fish. The enteric coating also includes ethylcellulose, sodium alginate, ammonium hydroxide, oleic acid, medium-chain triglycerides, and vegetable stearic acid, which should be considered when checking tolerability. A clinician can compare its total omega-3 quantity of 430 mg with other fish-oil products already in use and decide whether the labeled serving fits the individual’s medication and nutrition context.

Omega 3 BasiX™ supports overall nutritional coverage by supplying three named marine fatty acids in amounts that are easy to verify from the panel. EPA contributes 300 mg, DHA contributes 130 mg, and DPA contributes 12 mg within a total omega-3 quantity of 430 mg. XYMOGEN’s MaxSimil® process places those fats in monoacylglyceride form and the manufacturer characterizes that form as absorption ready. IFOS certification adds a product-specific quality detail concerning purity, freshness, and sustainability, while the enteric coating defines how the softgel is delivered. Together, these features let an adult supplement a diet that may be inconsistent in fatty fish without confusing the concentrate weight with the actual omega-3 content. Overall-health use remains a nutrition decision: the measured EPA, DHA, and DPA profile should be considered alongside food intake, medications, and any other concentrated oils in the person’s regimen.